Gary John
Gary John Clark, Constantia, NY US
Patent application number | Description | Published |
---|---|---|
20150365732 | LEGACY CONVERTER FILTER WITH EXTENDED FREQUENCY RANGE - What is presented is a legacy converter filter. The legacy converter filter comprises a first circuit that operates to substantially pass signals in a first frequency band of approximately 5 to 52 MHz; a second circuit that operates to substantially pass signals in a second frequency band of approximately 85 MHz to 2 GHz; and a third circuit that operates to substantially block signals in a third frequency band of approximately 52 MHz to 85 MHz. | 12-17-2015 |
Gary John Grevis, Nerang AU
Patent application number | Description | Published |
---|---|---|
20120291502 | REMOTELY OPERABLE VEHICLE COMPARTMENT LOCK - A remotely operable lock for a vehicle compartment includes a rotary latch; | 11-22-2012 |
Gary John Pederson, Jr., Albertville, MN US
Patent application number | Description | Published |
---|---|---|
20150306360 | Rotational Localized Drug Delivery Device - A drug delivery device that uses centrifugal force to deliver a drug to a body lumen wall. The drug delivery device comprises an impeller that includes an impeller shaft; an impeller head at the distal end of the impeller shaft; a drug lumen; an impeller housing; and a housing shaft attached to the impeller housing. In use, the drug is advanced along the drug lumen to the impeller head; at least the impeller head is rotated so that when drug exits the drug lumen, the centrifugal force of the rotating impeller causes the drug to move radially outward from the drug delivery device, towards and into the body lumen wall. | 10-29-2015 |
Gary John Pilafas, Hoffman Estates, IL US
Patent application number | Description | Published |
---|---|---|
20120047293 | METHOD AND APPARATUS OF STORAGE ARRAY WITH FRAME FORWARDING CAPABILITY - Embodiments of the invention provide a method of storage array with frame forwarding capability to reduce the complexity of an IT platform system having a large number of hardware devices. In one embodiment, a storage system comprises one or more storage devices; a storage controller having a storage controller processor and a storage controller memory and being coupled with the one or more storage devices; an interface controller receiving an input/output command directly from a host computer; and an internal bus. The interface controller and the storage controller are coupled by the internal bus. In another embodiment, a storage system comprises one or more storage devices; a storage controller having a processor and a memory and being coupled with the one or more storage devices; and a network interface controller which provides virtual Ethernet bridging. | 02-23-2012 |
Gary John Puppa, Orleans CA
Patent application number | Description | Published |
---|---|---|
20080298258 | Information transfer capability discovery apparatus and techniques - Information transfer capability discovery apparatus and techniques are disclosed. A received tracing message for tracing a communication path in a communication system is processed in some embodiments by generating and sending a response to the received tracing message. The tracing message response includes an indication of an information transfer capability of a communication link that comprises the communication path being traced by the tracing message. A further tracing message based on the received tracing message may also be forwarded in the communication system. The further tracing message may be associated with a different domain than the received tracing message in a communication system that includes multiple domains such as maintenance domains. In a multi-domain system, indications of information transfer capability could be included in further tracing messages instead of in responses. | 12-04-2008 |
Gary John Rocklitz, Burnsville, MN US
Patent application number | Description | Published |
---|---|---|
20140074751 | SYSTEM AND METHOD FOR CALCULATING FUTURE VALUE - A system and method for calculating, across one or more objects or portfolios, a probability distribution of values of a first parameter for one or more values of a second parameter (e.g., time). Probability distributions are assigned to each object at two or more different values of the second parameter. Each probability distribution defines a first parameter value distribution for that object at that particular value of the second parameter. Probability distributions of the first parameter across two or more objects or across a portfolio are calculated over changing values of the second parameter as a function of the probability distributions assigned to each object involved. | 03-13-2014 |
Gary John Smith, Hornsby AU
Patent application number | Description | Published |
---|---|---|
20140278928 | PLATFORM AND METHOD TO CONNECT ADVERTISERS WITH COMMUNITY GROUPS - An intermediary platform and method for connecting community groups with sponsors. Club information and membership information is obtained for a club. That information is analyzed to identify demographic and geographic characteristics of the membership. Those characteristics are matched against a pool of sponsors to identify a subset of possible sponsors. A sponsor website is created that is unique to the particular club including paid advertising from advertisers from the subset that agree to advertise on the club's sponsor site. Revenue from the advertising is shared with the club. Other embodiments are also described and claimed. | 09-18-2014 |
Gary John Tresadern, Toledo ES
Patent application number | Description | Published |
---|---|---|
20110009441 | IMIDAZO[1,2-A]PYRIDINE DERIVATIVES AND THEIR USE AS POSITIVE ALLOSTERIC MODULATORS OF MGLUR2 RECEPTORS - The present invention relates to novel compounds, in particular novel imidazo[1,2-a]piridine derivatives according to Formula (I). The compounds according to the invention are positive allosteric modulators of metabotropic receptors-sub-type 2 (‘mGluR2’) which are useful for the treatment or prevention of neurological and psychiatric disorders associated with glutamate dysfunction and diseases in which the mGluR2 subtype of metabotropic receptors is involved. In particular, such diseases are central nervous system disorders selected from the group of anxiety, schizophrenia, migraine, depression, and epilepsy. The invention is also directed to pharmaceutical compositions and processes to prepare such compounds and compositions, as well as to the use of such compounds for the prevention and treatment of such diseases in which mGluR2 is involved. | 01-13-2011 |
20120184525 | 1,2,3-TRIAZOLO [4,3-A] PYRIDINE DERIVATIVES AND THIER USE FOR THE TREATMENT OF PREVENTION OF NEUROLOGICAL AND PSYCHIATRIC DISORDERS - The present invention relates to novel triazolo[4,3- | 07-19-2012 |
20120252800 | BICYCLIC THIAZOLES AS ALLOSTERIC MODULATORS OF MGLUR5 RECEPTORS - The present invention relates to novel bicyclic thiazoles which are positive allosteric modulators of the metabotropic glutamate receptor subtype 5 (“mGluR5”) and which are useful for the treatment or prevention of disorders associated with glutamate dysfunction and diseases in which the mGluR5 subtype of receptors is involved. The invention is also directed to pharmaceutical compositions comprising such compounds, to processes for preparing such compounds and compositions, and to the use of such compounds and compositions for the prevention and treatment of disorders in which mGluR5 is involved. | 10-04-2012 |
20120258955 | BICYCLIC THIAZOLES AS ALLOSTERIC MODULATORS OF MGLUR5 RECEPTORS - The present invention relates to novel bicyclic thiazoles which are positive allosteric modulators of the metabotropic glutamate receptor subtype 5 (“mGluR5”) and which are useful for the treatment or prevention of disorders associated with glutamate dysfunction and diseases in which the mGluR5 subtype of receptors is involved. The invention is also directed to pharmaceutical compositions comprising such compounds, to processes for preparing such compounds and compositions, and to the use of such compounds and compositions for the prevention and treatment of disorders in which mGluR5 is involved. | 10-11-2012 |
20130079349 | 5-AMINO-3,6-DIHYDRO-1H-PYRAZIN-2-ONE DERIVATIVES USEFUL AS INHIBITORS OF BETA-SECRETASE (BACE) - The present invention relates to novel 5-amino-3,6-dihydro-1H-pyrazin-2-one derivatives as inhibitors of beta-secretase, also known as beta-site amyloid cleaving enzyme, BACE, BACE1, Asp2, or memapsin2. The invention is also directed to pharmaceutical compositions comprising such compounds, to processes for preparing such compounds and compositions, and to the use of such compounds and compositions for the prevention and treatment of disorders in which beta-secretase is involved, such as Alzheimer's disease (AD), mild cognitive impairment, senility, dementia, dementia with Lewy bodies, Down's syndrome, dementia associated with stroke, dementia associated with Parkinson's disease or dementia associated with beta-amyloid. | 03-28-2013 |
20130102618 | 3-AMINO-5,6-DIHYDRO-1H-PYRAZIN-2-ONE DERIVATIVES USEFUL FOR THE TREATMENT OF ALZHEIMER'S DISEASE AND OTHER FORMS OF DEMENTIA - The present invention relates to novel 3-amino-5,6-dihydro-1H-pyrazin-2-one derivatives as inhibitors of beta-secretase, also known as beta-site amyloid cleaving enzyme, BACE, BACE1, Asp2, or memapsin2. The invention is also directed to pharmaceutical compositions comprising such compounds, to processes for preparing such compounds and compositions, and to the use of such compounds and compositions for the prevention and treatment of disorders in which beta-secretase is involved, such as Alzheimer's disease (AD), mild cognitive impairment, senility, dementia, dementia with Lewy bodies, Down's syndrome, dementia associated with stroke, dementia associated with Parkinson's disease or dementia associated with beta-amyloid. | 04-25-2013 |
20130109683 | 5,6-DIHYDRO-2H-[1,4]OXAZIN-3-YL-AMINE DERIVATIVES USEFUL AS INHIBITORS OF BETA-SECRETASE (BACE) | 05-02-2013 |
20130190318 | 4,7-DIHYDRO-PYRAZOLO[1,5-a]PYRAZIN-6-YLAMINE DERIVATIVES USEFUL AS INHIBITORS OF BETA-SECRETASE (BACE) - The present invention relates to novel 4,7-dihydro-pyrazolo[1,5-a]pyrazin-6-yl-amine derivatives as inhibitors of beta-secretase, also known as beta-site amyloid cleaving enzyme, BACE, BACE1, Asp2, or memapsin2. The invention is also directed to pharmaceutical compositions comprising such compounds, to processes for preparing such compounds and compositions, and to the use of such compounds and compositions for the prevention and treatment of disorders in which beta-secretase is involved, such as Alzheimer's disease (AD), mild cognitive impairment, senility, dementia, dementia with Lewy bodies, Down's syndrome, dementia associated with stroke, dementia associated with Parkinson's disease or dementia associated with beta-amyloid. | 07-25-2013 |
20130252952 | 1,2,4-TRIAZOLO[4,3-a]PYRIDINE DERIVATIVES AND THEIR USE AS POSITIVE ALLOSTERIC MODULATORS OF MGLUR2 RECEPTORS - The present invention relates to novel triazolo[4,3-a]pyridine derivatives of Formula (I) | 09-26-2013 |
20130274266 | 5,6-DIHYDRO-IMIDAZO[1,2-a]PYRAZIN-8-YLAMINE DERIVATIVES USEFUL AS INHIBITORS OF BETA-SECRETASE (BACE) - The present invention relates to novel 5,6-dihydro-imidazo[1,2-a]pyrazin-8-ylamine derivatives as inhibitors of beta-secretase, also known as beta-site amyloid cleaving enzyme, BACE, BACE1, Asp2, or memapsin2. The invention is also directed to pharmaceutical compositions comprising such compounds, to processes for preparing such compounds and compositions, and to the use of such compounds and compositions for the prevention and treatment of disorders in which beta-secretase is involved, such as Alzheimer's disease (AD), mild cognitive impairment, senility, dementia, dementia with Lewy bodies, cerebrovascular amyloid angiopathy, multi-infarct dementia, Down's syndrome, dementia associated with stroke, dementia associated with Parkinson's disease or dementia associated with beta-amyloid. | 10-17-2013 |
20130338185 | 1,2,4-TRIAZOLO[4,3-a]PYRIDINE DERIVATIVES AND THEIR USE AS POSITIVE ALLOSTERIC MODULATORS OF MGLUR2 RECEPTORS - The present invention relates to novel triazolo[4,3-a]pyridine derivatives of Formula (I) | 12-19-2013 |
20140155393 | 1,2,4-TRIAZOLO[4,3-a]PYRIDINE DERIVATIVES AND THEIR USE AS POSITIVE ALLOSTERIC MODULATORS OF MGLUR2 RECEPTORS - The present invention relates to novel triazolo[4,3-a]pyridine derivatives of Formula (I) | 06-05-2014 |
20150141403 | 1,2,4-Triazolo [4,3-A] Pyridine Derivatives and Their Use For The Treatment of Prevention of Neurological and Psychiatric Disorders - The present invention relates to novel triazolo[4,3-a]pyridine derivatives of Formula (I) | 05-21-2015 |
Gary John Tresadern, Toleda ES
Patent application number | Description | Published |
---|---|---|
20110237580 | SUBSTITUTED BICYCLIC IMIDAZOLE DERIVATIVES AS GAMMA SECRETASE MODULATORS - The present invention is concerned with novel substituted bicyclic imidazole derivatives of Formula (I) | 09-29-2011 |
Gary John Vandersleen, Plainsboro, NJ US
Patent application number | Description | Published |
---|---|---|
20150278484 | Medical Data Acquisition and Patient Management System and Method - A sample analysis and medical data acquisition system for patient management includes a first user interface (UI) display module for displaying a medical chart page that includes selectable items associated with patient management. The first UI display module displays a set of medical delivery systems associated with a selectable medical delivery selection item, from which a medical delivery system is chosen. The system includes a second UI display module, in communication with the first UI display module, for displaying parameter fields for entry of operation data associated with the chosen medical delivery system. Medical data is captured from a patient by an analyzer configured to perform analysis of samples from the patient. The medical data is analyzed in accordance with entered operation data. The system includes an analysis display module, in communication with at least the first UI display module, for displaying sample analysis results. | 10-01-2015 |
Gary John Zyhowski, Lancaster, NY US
Patent application number | Description | Published |
---|---|---|
20110144216 | COMPOSITIONS AND USES OF CIS-1,1,1,4,4,4-HEXAFLUORO-2-BUTENE - This invention relates to compositions, methods and systems having utility in numerous applications, and in particular, uses for compositions containing the compound cis-1,1,1,4,4,4-hexafluoro-2-butene (Z-HFO-1336mzzm), which has the following structure: | 06-16-2011 |